newsfilter
← Latest News
GlobeNewswire·

Cullinan Therapeutics to Participate in Upcoming Investor Conferences

  • Cullinan Therapeutics (Nasdaq: CGEM) announced that CEO Nadim Ahmed and CMO Jeffrey Jones will attend the Stifel 2026 Healthcare Conference in New York on November 10, 2026, at 2:40 p.m. ET.
  • The same executives are scheduled to participate in the UBS Global Biopharma Conference 2026 in London on November 17, 2026, at 2:00 p.m. GMT (9:00 a.m. ET).
  • Webcasts of these fireside chats will be accessible via the Events and Presentations section of the company's investor relations website.
  • Cullinan Therapeutics is a clinical-stage biopharmaceutical company focused on developing disease-modifying T cell engagers for autoimmune diseases & cancer.
Company
Cullinan Therapeutics, Inc.
Keywords
Nasdaq:CGEM, Cullinan Therapeutics, Inc.